Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 15/20 | 0.55 |
| ▸ | HTR1A | P08908 | 8/20 | 0.48 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.40 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9178363 | 0.88 | SIGMAR1 (0.41) | SIGMAR1HTR1AGRIN2BDRD2DRD3 | |
| SCHEMBL9175467 | 0.86 | SIGMAR1 (0.40) | SIGMAR1HTR1AGRIN2B | |
| SCHEMBL2688223 | 0.85 | GRIN2B (0.55) | SIGMAR1HTR1AGRIN2B | |
| SCHEMBL9145145 | 0.83 | SIGMAR1 (0.45) | SIGMAR1HTR1AGRIN2BDRD2DRD3 | |
| SCHEMBL9179381 | 0.81 | ALDH1A1 (0.40) | SIGMAR1GRIN2B | |
| SCHEMBL9174172 | 0.81 | SIGMAR1 (0.43) | SIGMAR1HTR1AGRIN2BADRA2AADRA2C | |
| SCHEMBL9183292 | 0.79 | PREP (0.41) | SIGMAR1GRIN2B | |
| SCHEMBL9173695 | 0.78 | ALDH1A1 (0.37) | GRIN2B | |
| SCHEMBL8303444 | 0.78 | SIGMAR1 (0.55) | SIGMAR1DRD2 | |
| SCHEMBL8691572 | 0.76 | GRM2 (0.35) | SIGMAR1HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0490772-B1 | 1,4-Disubstituted piperazines, their process of preparation and pharmaceutical compositions containing them | ADIR (FR) | 1995-07-26 | — | — | EP | disclosed |
| US-5194437-A | Substituted with oxygen containing heterocycle, central nervous system disorders, neuroendocrine disorders | ADIR ET COMPAGNIE (FR) | 1993-03-16 | — | — | US | disclosed |
| EP-0490772-A1 | 1,4-Disubstituted piperazines, their process of preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1992-06-17 | — | — | EP | disclosed |